人类白细胞抗原-G对IVF/ICSI结局影响的Meta分析
该Meta分析纳入15项研究共6170例病例,比较胚胎培养基中含与不含可溶性人类白细胞抗原-G(sHLA-G)的植入率、临床妊娠率、多胎妊娠率及流产率;含sHLA-G组植入率与临床妊娠率显著更高,多胎妊娠率与流产率无显著差异。
要点
- 胚胎培养基含sHLA-G与植入率升高相关(OR 2.66,95%CI 1.75-4.06,P<0.00001)。
- 胚胎培养基含sHLA-G与临床妊娠率升高相关(OR 3.79,95%CI 2.69-5.33,P<0.00001)。
- 多胎妊娠率(OR 1.87,95%CI 0.55-6.31)与流产率(OR 0.77,95%CI 0.52-1.16)无显著差异。
核心结论
- 胚胎培养基中存在sHLA-G倾向于与更高的植入率和妊娠率相关。
- 该结论需采用更精确的sHLA-G测定方法开展进一步临床研究,并研究sHLA-G对早期胚胎发育和植入有益作用的生理与分子机制来巩固。
研究设计与样本
- 本分析纳入15项研究,共6170例病例,其中10项为前瞻性研究,5项为回顾性研究。
- 比较胚胎培养基中含与不含sHLA-G两组的植入、临床妊娠、多胎妊娠和流产结局。
主要发现
- 含sHLA-G的胚胎培养基与不含sHLA-G相比,植入率显著更高,OR为2.66(95%CI 1.75-4.06,P<0.00001)。
- 含sHLA-G的胚胎培养基与不含sHLA-G相比,临床妊娠率显著更高,OR为3.79(95%CI 2.69-5.33,P<0.00001)。
- 含与不含sHLA-G两组的多胎妊娠率无显著差异,OR为1.87(95%CI 0.55-6.31)。
- 含与不含sHLA-G两组的流产率无显著差异,OR为0.77(95%CI 0.52-1.16)。
临床怎么用
- 作者认为,胚胎培养基中存在sHLA-G倾向于与更高的植入率和妊娠率相关,该结论需进一步临床研究巩固。
局限性
- 原文指出结论需采用更精确的sHLA-G测定方法开展进一步临床研究来巩固。
- 原文指出需研究sHLA-G对早期胚胎发育和植入有益作用的生理与分子机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This analysis was performed to determine whether the presence of soluble human leukocyte antigen-G (sHLA-G) in embryo culture medium is predictive of clinical outcomes in IVF treatment. The outcomes of implantation, clinical pregnancy, multiple pregnancy and miscarriage, between groups with and without sHLA-G in embryo culture media, were analysed. Fifteen studies with a total of 6170 cases were included. Ten of them were prospective studies while five were retrospective studies. Embryo culture media with sHLA-G were associated with significantly higher implantation rate and clinical pregnancy rate when compared with those without; the odd ratios (ORs) were 2.66 [95% confidence interval (CI): 1.75-4.06, P < 0.00001], 3.79 (95% CI: 2.69-5.33, P < 0.00001), respectively. There was no significant difference in the rate of multiple pregnancy (OR: 1.87, 95% CI: 0.55-6.31) and miscarriage (OR: 0.77, 95% CI: 0.52-1.16). The results suggested that the presence of sHLA-G in the embryo culture medium favoured higher implantation rate and pregnancy rate. However, the conclusion needs to be consolidated by further clinical studies using a more precise method of determination of sHLA-G and research on the physiological and molecular mechanisms of the beneficial effect of sHLA-G on early embryo development and implantation.
引用
- Niu Z, Wang L, Pang RTK, et al. A meta-analysis of the impact of human leukocyte antigen-G on the outcomes of IVF/ICSI. Reprod Biomed Online. 2017. PMID: 28336163. doi:10.1016/j.rbmo.2017.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。